Niteesh K. Choudhry, M.D., Ph.D., is an internist and health services researcher whose work focuses on the development and evaluation of novel strategies to improve health care quality and reduce spending. He is particularly interested in the impact of insurance design and new methods of patient engagement on the use of and adherence to evidence-based therapies. Dr. Choudhry collaborates with a wide variety of insurers, employers and developers of new technologies. He leads a multidisciplinary research program funded by CVS Caremark to study medication adherence, cost-effectiveness and comparative effectiveness research.
Much of his recent work has dealt with the impact of medication costs and drug benefit design. Dr. Choudhry was the principal investigator of the Post-MI Free Rx and Event and Economic Evaluation (MI FREEE) trial, on the basis of which Aetna has changed their benefits to waive medication copayments for post-MI secondary prevention medications. While his work has centered on pharmaceuticals, Dr. Choudhry's interests also include other methods of enhancing health care quality and he is involved in designing and evaluating a variety of care innovations including retail clinics, ambulatory ICUs, methods to identify and target patients who would benefit from quality improvement interventions using electronic health data and mobile technologies to facilitate patient-provider interaction.
He has published over a 125 publications in the peer-reviewed literature in leading medical and policy journals, has won numerous awards for his work and lectures frequently throughout the U.S. and internationally on medication adherence, the economic evaluation of medical technologies and comparative effectiveness research Dr. Choudhry is an Associate Professor of Medicine at Harvard Medical School and an Associate Physician in the Division of Pharmacoepidemiology and Pharmacoeconomics and the Hospitalist Program at Brigham and Women's Hospital.
For a complete biography, click here.